| Announce Date | 02/05/2026 |
| EPS Normalized Actual | $1.47 (Beat by $0.27) |
| EPS GAAP Actual | $1.47 (Beat by $0.27) |
| Revenue Actual | $1.1887B |
| Revenue Surprise | Beat by $1188.7M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 6.3 | 6.77 | 6.14302 | 6.45698 | 1 |
| Dec 2028 | 5.0496 | 8.45 | 4.96924 | 5.15224 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0024 | 0.0024 | 1.1887B | 6.14% | 1188.7M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 1.1315B | 5.77% | 1131.5M |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 1.0041B | -15.18% | 1004.1M |
| FQ4 2024 (Dec 2024) | 1.62 | 1.62 | 1.0972B | -6.68% | 1097.2M |
| FQ3 2024 (Sep 2024) | 0.0867 | 0.0867 | 1.1157B | 15.08% | 1115.7M |
| FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 1.0662B | 4.07% | 1066.2M |
| FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 1.1565B | 13.01% | 1156.5M |
| FQ4 2023 (Dec 2023) | 0.33 | 0.33 | 1.1705B | 16.82% | 1170.5M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.69107 | -- | 1.66259 | 1.71955 | 1 |
| FQ3 2028 (Sep 2028) | 1.44925 | -- | 1.42484 | 1.47366 | 1 |
| FQ2 2028 (Jun 2028) | 1.37113 | -- | 1.34804 | 1.39422 | 1 |
| FQ1 2028 (Mar 2028) | 1.24661 | -- | 1.22561 | 1.26761 | 1 |
| FQ4 2027 (Oct 2027) | 0.9802 | -- | 0.9802 | 0.9802 | 1 |
| FQ3 2027 (Jul 2027) | 0.8853 | -- | 0.8853 | 0.8853 | 1 |
| FQ2 2027 (Jun 2027) | 1.1653 | -- | 1.14567 | 1.18493 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.13B | -- | 1.12B | 1.15B | 1 |
| FQ3 2028 (Sep 2028) | 1.11B | -- | 1.09B | 1.12B | 1 |
| FQ2 2028 (Jun 2028) | 1.1B | -- | 1.08B | 1.11B | 1 |
| FQ1 2028 (Mar 2028) | 1.1B | -- | 1.09B | 1.11B | 1 |
| FQ4 2027 (Oct 2027) | 1.03B | -- | 1.03B | 1.03B | 1 |
| FQ3 2027 (Jul 2027) | 1.03B | -- | 1.03B | 1.03B | 1 |
| FQ2 2027 (Jun 2027) | 1.04B | -- | 1.02B | 1.05B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0024 | 0.0024 | 100% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 0.14 | 0.14 | 100% | |
| FQ4 2024 (Dec 2024) | 1.62 | 1.62 | 100% | |
| FQ3 2024 (Sep 2024) | 0.0867 | 0.0867 | 100% | |
| FQ2 2024 (Jun 2024) | 1.08 | 1.08 | 100% | |
| FQ1 2024 (Mar 2024) | 1.03 | 1.03 | 100% | |
| FQ4 2023 (Dec 2023) | 0.33 | 0.33 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.19B | $1188.7M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.13B | $1131.5M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1B | $1004.1M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.1B | $1097.2M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.12B | $1115.7M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.07B | $1066.2M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.16B | $1156.5M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.17B | $1170.5M | 100% |